1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Ella Therapeutics Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC Fecal Microbial Transplantation by capsules - Melanoma Stage IV, Unresectable Melanoma | Phase 1 / Phase 2 | Unknown | Ella Therapeutics Ltd | 42 | 2020-11-01 | 2021-08-16 |
Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1)
Nivolumab (1)
Israel (1)